StopDown
Launch · 28 February 2026LemniscaDigital twin platform for fermentation

Lemnisca builds digital twin for bioprocess scale-up

By · Editor ·

pre-seed
  • Lemnisca is building a digital twin platform that simulates fermentation to help biotech manufacturers scale bioprocesses from lab to industrial volumes
  • The startup, founded by Shilpa Nargund and Pushkar Pendse, has built in-house wet lab capabilities to improve model accuracy and plans to take on one or two…
  • India's bio-economy has surged 16-fold to $165.7 billion in the last decade, and the global bioprocessing industry is growing at 11.39% CAGR to $228.73…

What happened

  • Lemnisca is building a digital twin platform for fermentation to help biotech manufacturers scale bioprocesses from lab to industrial volumes.
  • The platform uses a hybrid model that simulates living cell behaviour and physical conditions to predict bioprocess outcomes at scale.
  • The startup has built in-house wet lab capabilities to generate data for improving the accuracy of its digital twin model.
  • Lemnisca is agnostic to industry or product type; any molecule naturally made can be produced with microbes.
  • The company plans to take on one or two microbial processes in 2025, creating a specific product like a chemical or protein.
  • Its next milestone is to prove the technology is innovative and fit for a manufacturing setting.
  • Future growth could be horizontal (more processes across customers or molecule types) or vertical (multiple steps in manufacturing for one molecule).
  • The startup plans to cater equally to Indian and international customers.

Why it matters

  • India's bio-economy has surged 16-fold to $165.7 billion in the last 10 years.
  • The global bioprocessing industry is growing at 11.39% CAGR to $228.73 billion by 2033.
  • The Union Budget FY27 allocated ₹10,000 crore for the Biopharma Shakti scheme over five years to boost biologics and biosimilars.
  • India is the third-largest biotech market in Asia-Pacific and top 12 globally, but its share in the global biotech market is below 3%.
  • Lemnisca's digital twin for bioprocessing is unique in the Indian context.

The business

  • Lemnisca builds a digital twin platform for fermentation processes.
  • The platform uses a hybrid model simulating living cell behaviour and physical conditions.
  • It predicts bioprocess outcomes at scale, helping manufacturers move from lab to industrial volumes.
  • The startup has in-house wet lab capabilities to generate data for model accuracy.
  • Lemnisca is agnostic to industry or product type; any molecule naturally made can be produced with microbes.

The founders

Shilpa Nargund

founder
  • Holds a doctorate in chemical engineering.
  • Has 15 years of experience as a bioprocess industry veteran.
  • Previously worked at Insilico Biotechnology Singapore.

Pushkar Pendse

co-founder
  • Has expertise in modelling chemical processes.

In numbers

$228.73 BnGlobal bioprocessing industry size by 2033
11.39%Global bioprocessing industry CAGR
$165.7 BnIndia's bio-economy
₹10,000 croreUnion Budget allocation for Biopharma Shakti scheme · FY27

What happens next

  • Take on one or two microbial processes in 2025, creating a specific product like a chemical or protein.
  • Prove the technology is innovative and fit for a manufacturing setting.
  • Future growth could be horizontal (more processes across customers or molecule types) or vertical (multiple steps in manufacturing for one molecule).
  • Cater equally to Indian and international customers.

Up against

Differential Bio (Germany)Invert Bio (US)Insilico (Germany)

Words to know

digital twin
A virtual replica of a physical process or system that uses real-time data and simulation to predict outcomes and optimize performance.
fermentation
A biological process where microorganisms like bacteria or yeast convert organic substances into products such as chemicals, proteins, or medicines.
bioprocessing
The use of living cells or their components to produce desired products, such as drugs, enzymes, or biofuels, on a commercial scale.
wet lab
A laboratory where experiments involve handling liquids, chemicals, and biological materials, as opposed to computer-only simulations.

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.

All startup news on 28 February 2026 →

Is this Lemnisca? Get your “Featured on StopDown” badge →